enVVeno Medical Corporation (NVNO) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NVNO Revenue Growth
Revenue Breakdown (FY 2019)
NVNO's revenue distribution by segment and geography for fiscal year 2019
By Product/Segment
NVNO Revenue Analysis (2014–2025)
As of May 8, 2026, enVVeno Medical Corporation (NVNO) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, NVNO's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $785,912 in 2016.
Revenue diversification analysis shows NVNO's business is primarily driven by Royalty Income (100%). With over half of revenue concentrated in Royalty Income, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including VNRX (+40.0% YoY), TELA (+12.2% YoY), and NVCR (+8.5% YoY). Compare NVNO vs VNRX →
NVNO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NVNOCurrent | $0 | - | - | - | |
 VNRX | $2M | +40.0% | +164.1% | -1228.6% | |
 TELA | $69M | +12.2% | +35.0% | -49.2% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ANGO | $292M | +7.3% | +2.1% | -13.7% | |
 ELMD | $64M | +15.5% | +14.5% | 15.1% |
NVNO Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-20,899,000 | - |
| 2024 | $0 | - | $-528,000 | - | $-23,826,000 | - |
| 2023 | $0 | - | $-546,000 | - | $-25,238,000 | - |
| 2022 | $0 | - | $-525,000 | - | $-24,932,000 | - |
| 2021 | $0 | - | $-452,909 | - | $-16,892,503 | - |
| 2020 | $0 | -100.0% | $-383,972 | - | $-9,135,126 | - |
| 2019 | $31K | -83.3% | $31K | 100.0% | $-7,675,312 | -24566.5% |
| 2018 | $187K | -55.8% | $187K | 100.0% | $-7,854,785 | -4210.5% |
| 2017 | $422K | -46.3% | $-136,761 | -32.4% | $-6,103,247 | -1445.9% |
| 2016 | $786K | - | $-175,556 | -22.3% | $-4,659,183 | -592.8% |
See NVNO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVNO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NVNO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNVNO — Frequently Asked Questions
Quick answers to the most common questions about buying NVNO stock.
Is NVNO's revenue growth accelerating or slowing?
NVNO TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is NVNO's long-term revenue growth rate?
enVVeno Medical Corporation's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is NVNO's revenue distributed by segment?
NVNO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.